A citation-based method for searching scientific literature

McKenzie K Grundy, Ronald J Buckanovich, Kara A Bernstein. NAR Cancer 2020
Times Cited: 21



C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, Y H Ibrahim, A Gris-Oliver, S Bonache, B Morancho, A Bruna, O M Rueda, Z Lai, U M Polanska, G N Jones, P Kristel, L de Bustos, M Guzman, O Rodríguez, J Grueso, G Montalban, G Caratú, F Mancuso, R Fasani, J Jiménez, W J Howat, B Dougherty, A Vivancos, P Nuciforo, X Serres-Créixams, I T Rubio, A Oaknin, E Cadogan, J C Barrett, C Caldas, J Baselga, C Saura, J Cortés, J Arribas, J Jonkers, O Díez, M J O'Connor, J Balmaña, V Serra. Ann Oncol 2018
Times Cited: 170




List of shared articles



Times cited

CRISPR/Cas9‑induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer.
Hua Yang, Yaning Wei, Qian Zhang, Yang Yang, Xuebing Bi, Lin Yang, Na Xiao, Aimin Zang, Lili Ren, Xiaoli Li. Mol Med Rep 2022
0

New RAD51 Inhibitors to Target Homologous Recombination in Human Cells.
Irina S Shkundina, Alexander A Gall, Alexej Dick, Simon Cocklin, Alexander V Mazin. Genes (Basel) 2021
4

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.
Max M Wattenberg, Kim A Reiss. Cancers (Basel) 2021
3

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors.
Peng Gu, Liting Xue, Chunyan Zhao, Wenjing Li, Zhen Jiang, Aiguo Liu, Tingting Li, Lu Liu, Markus Decker, Xiaoxuan Cheng,[...]. Front Oncol 2022
0